Prestige Biopharma eyes at least 1.8t won valuation in Korean IPO

Retrieved on: 2021-01-19 21:45:00

Tags for this article:

Click the tags to see associated articles and topics

Prestige Biopharma eyes at least 1.8t won valuation in Korean IPO. View article details on hiswai:

Excerpt

Prestige Biopharma co-founder Lisa Park says that drug development has always been her "dream and goal". She reckons that the timing is now optimal ...

Article found on: www.businesstimes.com.sg

View Original Article